Komori
Other Disclosures8101GSI Creos CorporationTrading & Wholesale

Conducted a demonstration test of the Steri Wave apparatus for rendering infectious medical waste harmless and reducing its volume and weight

A group company conducted demonstration testing of STERILWAVE, a system that renders infectious medical waste harmless and reduces its volume and weight on-site, at a hospital and confirmed its processing performance. The company aims to expand its introduction at hospitals, local governments and other sites.

Worth reading
74In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
400
Approximately 400 kg of waste processed over 5 days
Wording
Conditional
How definitive the wording is.

Announced details

STERILWAVE (infectious medical waste sterilization and volume- and weight-reduction system)
Applicable field (uses covered by this announcement)

Infectious medical waste treatment, permanent installation at medical institutions, and waste treatment in disaster-affected areas

What the company reported numerically
Quantitative Effects

A model capable of processing 50 kg per hour was used. Approximately 400 kg was processed over 5 days, producing approximately 300 kg of residue. The system can reduce volume by up to approximately 80% and weight by approximately 25%.

Usage history

A total of approximately 400 kg was processed over 5 days in this demonstration test

Relationship between the counterparty and the company
GSI Creos Corporation8101
Relationship with the Company

Aizawa Hospital cooperated in the demonstration testing. 株式会社セントラル科学貿易 is a group company of the Company and the import agent for the system developed by France-based STERILWAVE.

CounterpartySocial Medical Corporation Foundation Jisenkai Aizawa Hospital

A hospital at 2-5-1 Honjo, Matsumoto, Nagano Prefecture. The chairperson and chief executive officer is Aizawa Takao (相澤孝夫).

Location (as indicated in this announcement)

Aizawa Hospital (2-5-1 Honjo, Matsumoto, Nagano Prefecture)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredSTERILWAVE (infectious medical waste sterilization and volume- and weight-reduction system)
CounterpartySocial Medical Corporation Foundation Jisenkai Aizawa Hospital
Counterparty overviewA hospital at 2-5-1 Honjo, Matsumoto, Nagano Prefecture. The chairperson and chief executive officer is Aizawa Takao (相澤孝夫).
Relationship with the CompanyAizawa Hospital cooperated in the demonstration testing. 株式会社セントラル科学貿易 is a group company of the Company and the import agent for the system developed by France-based STERILWAVE.
Applicable areaInfectious medical waste treatment, permanent installation at medical institutions, and waste treatment in disaster-affected areas
LocationAizawa Hospital (2-5-1 Honjo, Matsumoto, Nagano Prefecture)
Quantitative EffectsA model capable of processing 50 kg per hour was used. Approximately 400 kg was processed over 5 days, producing approximately 300 kg of residue. The system can reduce volume by up to approximately 80% and weight by approximately 25%.
Usage historyA total of approximately 400 kg was processed over 5 days in this demonstration test
Items this document does not state (10)
Contract ValueOffering priceContract DateLaunch dateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To verify the system’s practicality and operational performance in medical settings, and to help address issues including rising costs for infectious medical waste disposal and the environmental impact of incineration.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Conducted a demonstration test of the Steri Wave apparatus for rendering infectious medical waste harmless and reducing its volume and weight | GSI Creos Corporation (8101) timely disclosure | Komori